急性冠状动脉综合征的进展：弥合诊断与治疗的差距
Advances in Acute Coronary Syndromes: Bridging Gaps in Diagnosis and Treatment.
作者信息
Andò Giuseppe, Micari Antonio, Costa Francesco
机构信息
Department of Clinical and Experimental Medicine, University of Messina, Azienda Ospedaliera Universitaria Policlinico "Gaetano Martino", 98124 Messina, Italy.
Department of Biomedical and Dental Sciences and of Morphological and Functional Images, University of Messina, Azienda Ospedaliera Universitaria Policlinico "Gaetano Martino", 98124 Messina, Italy.
出版信息
J Clin Med. 2024 Oct 9;13(19):6003. doi: 10.3390/jcm13196003.
Abstract
Acute coronary syndromes (ACS) have long posed a formidable challenge to cardiovascular care, despite significant advancements in both understanding and treatment over the last few decades [...].
摘要
尽管在过去几十年里，我们对急性冠状动脉综合征（ACS）的认识和治疗都取得了重大进展，但它长期以来一直是心血管护理领域面临的一项艰巨挑战。
相似文献
1
Advances in Acute Coronary Syndromes: Bridging Gaps in Diagnosis and Treatment.急性冠状动脉综合征的进展：弥合诊断与治疗的差距
J Clin Med. 2024 Oct 9;13(19):6003. doi: 10.3390/jcm13196003.
2
Capturing the pathophysiology of acute coronary syndromes with circulating biomarkers.用循环生物标志物捕捉急性冠状动脉综合征的病理生理学。
Rev Cardiovasc Med. 2010;11 Suppl 2:S3-12. doi: 10.3909/ricm11S2S0005.
3
Use of novel antiplatelet agents in acute coronary syndromes.新型抗血小板药物在急性冠脉综合征中的应用。
Curr Atheroscler Rep. 2015 Mar;17(3):483. doi: 10.1007/s11883-014-0483-4.
4
Management of acute coronary syndromes in Mexico: gaps and opportunities to improve outcomes.墨西哥急性冠状动脉综合征的管理：改善治疗结果的差距与机遇
Am J Cardiovasc Drugs. 2009;9(3):143-8. doi: 10.1007/BF03256571.
5
Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes.出血与急性冠状动脉综合征：风险与预后的定义、预测和管理。
Curr Drug Targets. 2011 Nov;12(12):1831-5. doi: 10.2174/138945011797635876.
6
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTalian cardiac care units Registry.经皮冠状动脉介入治疗的急性冠状动脉综合征患者在导管室中的抗血栓策略：来自意大利心脏护理单位住院的急性冠状动脉综合征患者中使用的抗血栓治疗的见解登记处。
J Cardiovasc Med (Hagerstown). 2017 Aug;18(8):580-589. doi: 10.2459/JCM.0000000000000533.
7
A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS).欧洲和地中海地区急性冠脉综合征患者的特征、治疗及预后的前瞻性调查；欧洲急性冠脉综合征心脏调查（欧洲心脏调查急性冠脉综合征）
Eur Heart J. 2002 Aug;23(15):1190-201. doi: 10.1053/euhj.2002.3193.
8
Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry.光学相干断层成像术评估他汀类药物对急性冠状动脉综合征患者斑块破裂的影响：来自光学相干断层成像术（OCT）-FORMIDABLE 注册研究的结果。
Eur Heart J Cardiovasc Imaging. 2018 May 1;19(5):524-531. doi: 10.1093/ehjci/jex102.
9
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.老年人急性冠脉护理，第一部分：非ST段抬高型急性冠脉综合征：美国心脏协会临床心脏病学委员会为医疗专业人员发布的科学声明：与老年心脏病学会合作制定
Circulation. 2007 May 15;115(19):2549-69. doi: 10.1161/CIRCULATIONAHA.107.182615.
10
From Mars to Venus: Gender Differences in the Management and Outcomes of Acute Coronary Syndromes.从火星到金星：急性冠脉综合征管理与结局中的性别差异
Curr Pharm Des. 2016;22(25):3790-801. doi: 10.2174/1381612822666160328113831.
引用本文的文献
1
Integrated risk factors for premature acute coronary syndrome: residual cholesterol, RDW, and BMI.早发急性冠状动脉综合征的综合危险因素：残余胆固醇、红细胞分布宽度和体重指数。
Front Cardiovasc Med. 2025 Jun 26;12:1574620. doi: 10.3389/fcvm.2025.1574620. eCollection 2025.
本文引用的文献
1
Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US Sample.经皮冠状动脉介入治疗后主要不良心血管事件的当代预测因素：一项具有全国代表性的美国样本研究
J Clin Med. 2024 May 11;13(10):2844. doi: 10.3390/jcm13102844.
2
The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome.急性冠状动脉综合征管理的发展领域：对2023年欧洲心脏病学会急性冠状动脉综合征管理指南的批判性评估
J Clin Med. 2024 Mar 25;13(7):1885. doi: 10.3390/jcm13071885.
3
Dual Antiplatelet Therapy with Parenteral P2Y Inhibitors: Rationale, Evidence, and Future Directions.使用肠外P2Y抑制剂的双重抗血小板治疗：理论依据、证据及未来方向
J Cardiovasc Dev Dis. 2023 Apr 9;10(4):163. doi: 10.3390/jcdd10040163.
4
The Impact of Emergency Department Arrival Time on Door-to-Balloon Time in Patients with ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention.急诊科到达时间对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者门球时间的影响。
J Clin Med. 2023 Mar 20;12(6):2392. doi: 10.3390/jcm12062392.
5
GP IIb/IIIa Receptor Inhibitors in Mechanically Ventilated Patients with Cardiogenic Shock due to Myocardial Infarction in the Era of Potent P2Y12 Receptor Antagonists.强效P2Y12受体拮抗剂时代，机械通气的心肌梗死所致心源性休克患者使用糖蛋白IIb/IIIa受体抑制剂的情况
J Clin Med. 2022 Dec 14;11(24):7426. doi: 10.3390/jcm11247426.
6
P2Y Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-Analysis.经皮冠状动脉介入治疗后双联抗血小板治疗后应用 P2Y 抑制剂或阿司匹林：网状荟萃分析。
JACC Cardiovasc Interv. 2022 Nov 28;15(22):2239-2249. doi: 10.1016/j.jcin.2022.08.009. Epub 2022 Oct 26.
7
Incidence, Predictive Factors and Long-Term Clinical Impact of Left Ventricular Remodeling According to the Completeness of Revascularization in Patients with ST-Elevation Myocardial Infarction and Multivessel Disease.ST段抬高型心肌梗死合并多支血管病变患者左心室重构的发生率、预测因素及根据血运重建完整性的长期临床影响
J Clin Med. 2022 Oct 23;11(21):6252. doi: 10.3390/jcm11216252.
8
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study.一项使用最新一代佐他莫司洗脱支架进行左主干 PCI 的大型前瞻性多中心研究：ROLEX 研究。
EuroIntervention. 2023 Feb 6;18(13):e1108-e1119. doi: 10.4244/EIJ-D-22-00454.
9
Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials.双联或三联抗栓治疗在冠状动脉支架置入术后和心房颤动中的应用：一项随机临床试验的系统评价和荟萃分析。
Int J Cardiol. 2020 Mar 1;302:95-102. doi: 10.1016/j.ijcard.2019.12.054. Epub 2019 Dec 28.
10
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome.急性冠状动脉综合征患者行全剂量或低剂量比伐芦定术后输注。
J Am Coll Cardiol. 2019 Feb 26;73(7):758-774. doi: 10.1016/j.jacc.2018.12.023.
Zotero 插件